Application of a graded management program of hand-foot syndrome in patients with breast cancer who received chemotherapy

doi:10.3761/j.issn.0254-1769.2023.21.003

Abstract

Abstract:

Objective To investigate the application effect of a graded management program of hand-foot syndrome（HFS） in patients with breast cancer who received chemotherapy. Methods Convenience sampling method was adopted to select breast cancer patients who received chemotherapy in the breast surgery department of a tertiary A hospital in Wuhan. According to the time of admission，55 patients admitted from April 2022 to September 2022 were included in the experimental group，in which the graded management program was carried out according to the occurrence of HFS. 55 patients admitted from October 2021 to March 2022 were included in the control group，in which the routine chemotherapy care was carried out. Interventions in both groups lasted until 3 days after the last chemotherapy. The incidence of HFS and its impact on quality of life 3 days after the final chemotherapy were compared between the 2 groups. Results The incidence of HFS was 34.55% in the experimental group and 58.18% in the control group，and there were significant differences in the incidence and grade of HFS between the 2 groups（P<0.05）. The total score of life quality scale in the experimental group was 15.00（13.00，17.00） and 19.00（17.00，22.00） in the control group. The life quality of patients in the experimental group was significantly higher than that in the control group（P<0.001）. Conclusion The graded management program for breast cancer patients with HFS can reduce the incidence and grade of HFS，and can help to improve the quality of life in breast cancer patients who received chemotherapy.

Key words: Breast Neoplasms, Hand-Foot Syndrome, Nursing Care

摘要： 目的探讨手足综合征分级护理在乳腺癌化疗患者中的应用效果。方法采取便利抽样法，选取武汉市某三级甲等医院乳腺外科行化疗的乳腺癌患者，按照入院时间将2022年4月—9月收治的55例患者纳入试验组，根据患者的手足综合征发生情况进行分级管理，将2021年10月—2022年3月收治的55例患者纳入对照组，予以化疗常规护理，两组干预措施均持续到最后1次化疗结束后3 d，比较两组最终化疗结束后3 d手足综合征发生情况及其对生活质量的影响。结果试验组、对照组的手足综合征发生率分别为34.55%、58.18%，两组手足综合征发生率及发生等级差异均具有统计学意义（P<0.05）；试验组手足皮肤反应患者生活质量量表总分为15.00（13.00，17.00）分，对照组为19.00（17.00，22.00）分，试验组的生活质量高于对照组，差异具有统计学意义（P<0.001）。结论实施手足综合征分级护理有利于降低乳腺癌化疗患者的手足综合征发生率，提高其生活质量。

关键词: 乳腺肿瘤, 手足综合征, 护理

CHU Yanxiang, DENG Yan, XIONG Huan. Application of a graded management program of hand-foot syndrome in patients with breast cancer who received chemotherapy[J]. Chinese Journal of Nursing, 2023, 58(21): 2583-2588.

褚彦香, 邓妍, 熊欢. 手足综合征分级护理在乳腺癌化疗患者中的应用[J]. 中华护理杂志, 2023, 58(21): 2583-2588.

Figures/Tables 2

References 27

[1]	张方圆, 吕苏梅, 杨玄, 等. 中国癌症症状管理实践指南——皮肤反应[J]. 护士进修杂志, 2019, 34(22):2017-2024.
	Zhang FY, Lü SM, Yang X, et al. China cancer symptom management practice guideline:skin reaction[J]. J Nurses Train, 2019, 34(22):2017-2024.
[2]	Hofheinz RD, Gencer D, Schulz H, et al. Mapisal versus urea cream as prophylaxis for capecitabine-associated hand-foot syndrome:a randomized phase Ⅲ trial of the AIO quality of life working group[J]. J Chin Oncol, 2015, 33(22):2444-2449.
[3]	Ajgal Z, Chapuis N, Emile G, et al. Risk factors for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia over time:assessment of monocyte count and baseline clinical parameters[J]. Cancer Chemother Pharmacol, 2015, 76(5):1033-1039. DOI URL
[4]	中国医师协会肿瘤医师分会乳腺癌学组. 聚乙二醇化脂质体多柔比星不良反应管理中国专家共识(2020版)[J]. 中华肿瘤杂志, 2020, 42(8):617-623.
	Breast Cancer Group, Chinese Association for Clinical Oncologist CACO. Chinese expert consensus on management of adverse events of pegylated liposomal doxorubicin(2020 edition)[J]. Chin J Oncol, 2020, 42(8):617-623.
[5]	胡丽莎, 彭红华, 米元元, 等. 肿瘤靶向治疗患者皮肤不良反应预防及管理的证据总结[J]. 中华护理杂志, 2022, 57(9):1061-1069. DOI
	Hu LS, Peng HH, Mi YY, et al. Evidence summary for prevention and management of the skin adverse reactions in patients with targeted tumor therapy[J]. Chin J Nurs, 2022, 57(9):1061-1069. DOI
[6]	倪平, 陈京立, 刘娜. 护理研究中量性研究的样本量估计[J]. 中华护理杂志, 2010, 45(4):378-380.
	Ni P, Chen JL, Liu N. The sample size estimation in quantitative nursing research[J]. Chin J Nurs, 2010, 45(4):378-380.
[7]	谢探, 潘红英, 李舒琦, 等. 局部冷敷法在预防脂质体阿霉素相关手足综合征中的应用研究[J]. 护理与康复, 2021, 20(2):79-81.
	Xie T, Pan HY, Li SQ, et al. Application of local cold compress in prevention of liposomal adriamycin associated hand and foot syndrome[J]. J Nurs Rehabil, 2021, 20(2):79-81.
[8]	胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2018.
	Hu Y, Hao YF. Evidence-based nursing[M]. 2nd ed. Beijing: People’s Medical Publishing House, 2018.
[9]	董雪, 王雪, 苏伟才, 等. 局部冷敷对乳腺癌患者应用盐酸多柔比星脂质体致手足综合征的临床研究[J]. 中国医刊, 2020, 55(10):1151-1153.
	Dong X, Wang X, Su WC, et al. Clinical study on doxorubicin hydrochloride liposome induced hand-foot syndrome induced by local cold compress in breast cancer patients[J]. Chin J Med, 2020, 55(10):1151-1153.
[10]	Lan TC, Tsou PH, Tam KW, et al. Effect of urea cream on hand-foot syndrome in patients receiving chemotherapy:a meta-analysis[J]. Cancer Nurs, 2021, 45(5):378-386. DOI URL
[11]	杨玉兰, 钟娇, 卢宏达. 按摩预防化疗患者手足局部不良反应效果观察[J]. 护理学杂志, 2014, 29(12):54-55.
	Yang YL, Zhong J, Lu HD. Effect of foot and hand message on local adverse reactions of chemotherapy patients[J]. J Nurs Sci, 2014, 29(12):54-55.
[12]	谭启明. 复方利多卡因乳膏应用于无痛护理的研究进展[J]. 中华现代护理杂志, 2013, 19(26):3302-3304.
	Tan QM. Research progress of compound Lidocaine cream in painless nursing[J]. Chin J Mod Nurs, 2013, 19(26):3302-3304.
[13]	董元鸽, 陆箴琦, 杨瑒. 卡培他滨致手足综合征的护理研究进展[J]. 护理研究, 2016, 30(3):275-278.
	Dong YG, Lu ZQ, Yang Y. Research progress on nursing care of patients with hand-foot syndrome caused by capecitabine[J]. Chin Nurs Res, 2016, 30(3):275-278.
[14]	贾立群, 贾英杰, 陈冬梅, 等. 手足综合征中医辨证分型及治法方药专家共识[J]. 中医杂志, 2022, 63(6):595-600.
	Jia LQ, Jia YJ, Chen DM, et al. Expert consensus on TCM syndrome differentiation and treatment of hand-foot syndrome[J]. J Tradit Chin Med, 2022, 63(6):595-600.
[15]	Sydor A. Targeted therapy:epidermal growth factor receptor inhibitor(EGFRI) assocliated dermatitis[EB/OL]. (2019-01-10)[2021-10-03]. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=jbi&NEWS=N&AN=JBI16059.
[16]	Anderson RT, Keating KN, Doll HA, et al. The Hand-Foot Skin Reaction and Quality of Life Questionnaire:an assessment tool for oncology[J]. The Oncol, 2015, 20(7):831-838. DOI URL
[17]	于然, 娄彦妮, 贾立群. 手足皮肤反应患者生活质量量表汉化及信效度分析[J]. 中国中西医结合皮肤性病学杂志, 2020, 19(2):142-144.
	Yu R, Lou YN, Jia LQ. Sinicization and reliability and validity analysis of Quality of Life Scale for Patients with Hand and Foot Skin Reaction[J]. Chin J Dermatovenereol Integr Tradit West Med, 2020, 19(2):142-144.
[18]	Zaiem A, Hammamia SB, Aouinti I, et al. Hand-foot syndrome induced by chemotherapy drug:case series study and literature review[J]. Indian J Pharmacol, 2022, 54(3):208-215.
[19]	Skubitz KM, Lindgren BR, Domingo ME, et al. Prospective trial of monocyte count as a biomarker of hand-foot syndrome among patients with soft tissue sarcomas treated with pegylated liposomal doxorubicin and ifosfamide[J]. Cureus, 2022, 14(4):e24498.
[20]	Azami G, Soh KL, Sazlina SG, et al. Effect of a nurse-led diabetes self-management education program on glycosylated hemoglobin among adults with type 2 diabetes[J]. J Diabetes Res, 2018, 2018:4930157.
[21]	凌瑛, 应燕萍, 陈莹莹, 等. 乳腺癌化疗病人Triangle分层分级管理模式的构建与应用研究[J]. 全科护理, 2021, 19(33):4655-4658.
	Ling Y, Ying YP, Chen YY, et al. Construction and application of triangle hierarchical management model for breast cancer patients undergoing chemotherapy[J]. Chin Gen Pract Nurs, 2021, 19(33):4655-4658.
[22]	Murugan K, Ostwal V, Carvalho MD, et al. Self-identification and management of hand-foot syndrome(HFS):effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer[J]. Support Care Cancer, 2016, 24(6):2575-2581. DOI URL
[23]	陈小知, 蔡建平, 陶丽, 等. 乳腺癌化疗患者手足综合征症状体验的质性研究[J]. 护理管理杂志, 2019, 19(10):715-718.
	Chen XZ, Cai JP, Tao L, et al. Breast cancer patients with chemotherapy-induced hand-foot syndrome:a qualitative study of symptom experience[J]. J Nurs Admin, 2019, 19(10):715-718.
[24]	Lamprell K, Arnolda G, Delaney GP. The challenge of puttingprinciples into practice:resource tensions and real-world con- straints in multidisciplinary oncology team meetings[J]. Asia Pac J Clin Oncol, 2019, 15(4):199-207. DOI URL
[25]	Ilyas S, Wasif K, Saif MW. Topical henna ameliorated capecitabi-ne-induced hand-foot syndrome[J]. Cutan Ocul Toxicol, 2014, 33(3):253-255. DOI URL
[26]	周玉球, 韦炜, 黄波, 等. 督脉灸联合中药泡洗及护理干预对卡培他滨相关性手足综合征的预防效果[J]. 当代护士(上旬刊), 2022, 29(5):89-91.
	Zhou YQ, Wei W, Huang B, et al. Prevention of capecitabine-related hand-foot syndrome by moxibustion combined with Traditional Chinese Medicine soaking and nursing intervention[J]. Today Nurs, 2022, 29(5):89-91.
[27]	于然, 贾立群, 裴育莹, 等. 中药复方LC09颗粒泡洗联合尿素软膏治疗抗肿瘤靶向药物多激酶抑制剂致手足皮肤反应的随机对照双盲临床研究[J]. 中医杂志, 2020, 61(23):2078-2081.
	Yu R, Jia LQ, Pei YY, et al. Study on Traditional Chinese Medicine compound LC09 granule soaking combined with urea ointment in the treatment of hand-foot skin reactions caused by anti-tumor targeted drug multikinase inhibitors:a randomized-controlled double-blind clinical trial[J]. J Tradit Chin Med, 2020, 61(23):2078-2081.